Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anand Rohatgi

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 27, 2018
Reverse Cholesterol Transport and AtherosclerosisAnand Rohatgi
Progress in Cardiovascular Diseases|May 14, 2015
High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux CapacityAnand Rohatgi
Circulation|May 17, 2021
Stressing the Endothelium to Assess Localized Inflammatory Potential and the Risk for Atherosclerotic Cardiovascular DiseaseAnand Rohatgi
Future Cardiology|May 14, 2010
Cholesterol screening in children: makes sense but what is the impact?Anand Rohatgi
JAMA Cardiology|January 18, 2023
Higher High-Density Lipoprotein Cholesterol-Good Omen, Bad Omen, or Not an Omen at AllJohn Wilkins, Anand Rohatgi
Current Atherosclerosis Reports|June 7, 2015
Niacin Therapy, HDL Cholesterol, and Cardiovascular Disease: Is the HDL Hypothesis Defunct?Preethi Mani, Anand Rohatgi
Current Atherosclerosis Reports|January 22, 2014
The role of advanced lipid testing in the prediction of cardiovascular diseaseAlvin Chandra, Anand Rohatgi
Journal of Thoracic Disease|March 31, 2018
Examining the paradox of high high-density lipoprotein and elevated cardiovascular riskKavisha Singh, Anand Rohatgi
Current Opinion in Lipidology|May 24, 2016
Modulating cholesterol efflux capacity to improve cardiovascular diseaseNicholas Brownell, Anand Rohatgi
Current Atherosclerosis Reports|December 30, 2015
HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic TargetAnish Bhatt, Anand Rohatgi
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Arteriosclerosis, Thrombosis, and Vascular Biology|December 27, 2018
Reverse Cholesterol Transport and AtherosclerosisAnand Rohatgi
Progress in Cardiovascular Diseases|May 14, 2015
High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux CapacityAnand Rohatgi
Circulation|May 17, 2021
Stressing the Endothelium to Assess Localized Inflammatory Potential and the Risk for Atherosclerotic Cardiovascular DiseaseAnand Rohatgi
Future Cardiology|May 14, 2010
Cholesterol screening in children: makes sense but what is the impact?Anand Rohatgi
JAMA Cardiology|January 18, 2023
Higher High-Density Lipoprotein Cholesterol-Good Omen, Bad Omen, or Not an Omen at AllJohn Wilkins, Anand Rohatgi
Current Atherosclerosis Reports|June 7, 2015
Niacin Therapy, HDL Cholesterol, and Cardiovascular Disease: Is the HDL Hypothesis Defunct?Preethi Mani, Anand Rohatgi
Current Atherosclerosis Reports|January 22, 2014
The role of advanced lipid testing in the prediction of cardiovascular diseaseAlvin Chandra, Anand Rohatgi
Journal of Thoracic Disease|March 31, 2018
Examining the paradox of high high-density lipoprotein and elevated cardiovascular riskKavisha Singh, Anand Rohatgi
Current Opinion in Lipidology|May 24, 2016
Modulating cholesterol efflux capacity to improve cardiovascular diseaseNicholas Brownell, Anand Rohatgi
Current Atherosclerosis Reports|December 30, 2015
HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic TargetAnish Bhatt, Anand Rohatgi
Pageof 12